Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jun 12;5(1):95.
doi: 10.1038/s41392-020-0210-2.

Multi-cancer blood testing combined with PET-CT: road for hope to screen for cancer and guide intervention

Affiliations
Comment

Multi-cancer blood testing combined with PET-CT: road for hope to screen for cancer and guide intervention

Tao Jiang et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Traditional vs. novel cancer screening approach. Novel cancer screening approach would integrate the multi-cancer blood testing into traditional standard-of-care strategies

Comment on

  • Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.
    Lennon AM, Buchanan AH, Kinde I, Warren A, Honushefsky A, Cohain AT, Ledbetter DH, Sanfilippo F, Sheridan K, Rosica D, Adonizio CS, Hwang HJ, Lahouel K, Cohen JD, Douville C, Patel AA, Hagmann LN, Rolston DD, Malani N, Zhou S, Bettegowda C, Diehl DL, Urban B, Still CD, Kann L, Woods JI, Salvati ZM, Vadakara J, Leeming R, Bhattacharya P, Walter C, Parker A, Lengauer C, Klein A, Tomasetti C, Fishman EK, Hruban RH, Kinzler KW, Vogelstein B, Papadopoulos N. Lennon AM, et al. Science. 2020 Jul 3;369(6499):eabb9601. doi: 10.1126/science.abb9601. Epub 2020 Apr 28. Science. 2020. PMID: 32345712 Free PMC article.

References

    1. Lennon AM, et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science. 2020 doi: 10.1126/science.abb9601. - DOI - PMC - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 2020;70:7–30. doi: 10.3322/caac.21590. - DOI - PubMed
    1. Smith RA, et al. Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J. Clin. 2018;68:297–316. doi: 10.3322/caac.21446. - DOI - PubMed
    1. Taylor WC. Comment on “Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA” by M. C. Liu et al. Ann. Oncol. 2020 doi: 10.1016/j.annonc.2020.04.013. - DOI - PMC - PubMed
    1. Cohen JD, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359:926–930. doi: 10.1126/science.aar3247. - DOI - PMC - PubMed

Publication types

Substances